<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<html>
<head>
	<meta http-equiv="content-type" content="text/html; charset=utf-8"/>
	<title></title>
	<meta name="generator" content="LibreOffice 5.0.2.2 (Linux)"/>
	<meta name="author" content="HenryLaptop"/>
	<meta name="created" content="2015-02-15T11:16:00"/>
	<meta name="changedby" content="HenryLaptop"/>
	<meta name="changed" content="2015-02-15T11:16:00"/>
	<meta name="AppVersion" content="14.0000"/>
	<meta name="DocSecurity" content="0"/>
	<meta name="HyperlinksChanged" content="false"/>
	<meta name="LinksUpToDate" content="false"/>
	<meta name="ScaleCrop" content="false"/>
	<meta name="ShareDoc" content="false"/>
	<style type="text/css">
		@page { size: 8.5in 11in; margin: 1in }
		p { margin-bottom: 0.1in; direction: ltr; line-height: 120%; text-align: left; orphans: 2; widows: 2 }
		a:link { color: #0000ff }
	</style>
</head>
<body lang="en-US" link="#0000ff" dir="ltr">
<p style="margin-bottom: 0.05in; line-height: 100%"><font color="#005c46"><font face="Arial, serif"><font size="6" style="font-size: 24pt"><b>Targeted
therapy for stomach cancer</b></font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#444444"><font face="Arial, serif"><font size="3" style="font-size: 11pt"><b>Occasionally,
a targeted therapy drug called&nbsp;</b></font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Biologicaltherapies/Monoclonalantibodies/Trastuzumab.aspx"><font color="#6ba71c"><font face="Arial, serif"><font size="3" style="font-size: 11pt"><b>trastuzumab
(HerceptinÂ®)</b></font></font></font></a><font color="#444444"><font face="Arial, serif"><font size="3" style="font-size: 11pt"><b>&nbsp;is
given with chemotherapy for advanced stomach cancer.</b></font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Targeted
therapy drugs interfere with the way cancer cells grow.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Trastuzumab
only works for people with a stomach cancer that has high levels of a
protein called HER2. About 1 in 5 people with stomach cancer (20%)
have this. Tests can be done on tissue taken at a biopsy or during
surgery to find out if the cancer cells have high levels of HER2.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Trastuzumab
attaches to the HER2 proteins on the surface of the cancer cells.
This stops the cancer cells from dividing and growing.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Trastuzumab
is given as a drip (infusion) every three weeks. If it works well,
your doctor may decide to carry on giving it after your chemotherapy
has stopped. The side effects of trastuzumab are usually mild.</font></font></font></p>
<p style="margin-top: 0.05in; margin-bottom: 0.12in; line-height: 100%">
<font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">Doctors
are testing other targeted therapy drugs in&nbsp;</font></font></font><a href="http://www.macmillan.org.uk/Cancerinformation/Cancertypes/Stomach/Treatingstomachcancer/Research-clinicaltrials.aspx"><font color="#6ba71c"><font face="Arial, serif"><font size="2" style="font-size: 9pt">clinical
trials</font></font></font></a><font color="#777777"><font face="Arial, serif"><font size="2" style="font-size: 9pt">.</font></font></font></p>
<p style="margin-bottom: 0.14in; line-height: 115%"><br/>
<br/>

</p>
</body>
</html>